Fluor-18-FDG
Sponsors
Aalborg University Hospital, Rigshospitalet
Conditions
Breast cancerGastric cancerGastroesophageal junction cancer (GEJ-cancer)Malignant melanomaNeuroendocrine neoplasmsOvarian CancerPleural Mesotheliomalymphomas
Phase 2
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging of Patients with Ovarian Cancer
RecruitingCTIS2023-505938-98-00
Start: 2023-11-17Target: 50Updated: 2025-03-10
68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging after Chemotherapy in Patients with Gastric and Gastro-esophageal Junctional Cancer
CompletedCTIS2023-505916-40-01
Start: 2024-02-15End: 2025-12-18Target: 20Updated: 2025-03-10
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients with Neuroendocrine Neoplasms
RecruitingCTIS2024-516156-18-00
Start: 2023-01-17Target: 200Updated: 2024-08-20
Phase IIa Clinical Trial: Feasibility Study on Non-Invasive Simultaneous Hyperpolarized [1-13C]Pyruvate Magnetic Resonance Spectroscopy and 18F-FDG PET (hyperPET) for Metabolic Imaging in Patients with Cancer
RecruitingCTIS2024-516131-28-00
Start: 2022-04-18Target: 15Updated: 2024-08-28
FAPI PET in Pleural Mesothelioma: The Diagnostic Accuracy and Clinical Value of FAPI PET at Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation
RecruitingCTIS2024-514301-62-00
Start: 2025-01-29Target: 70Updated: 2024-10-07
BEFAST STUDY: [68Ga]Ga-FAPI total body PET/CT for Better and Faster imaging in cancer
[68Ga]Ga-FAPI PET/CT for response evaluation during immune checkpoint inhibitor therapy in malignant melanoma
RecruitingCTIS2023-509549-11-00
Start: 2025-08-03Target: 20Updated: 2025-06-02